↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant(2008).„Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4: 217-241.DOI:10.1016/S1574-1400(08)00012-1.
↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP.(2012).„ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID21948594.edit
↑Fischer-Cornelssen,K. A.(1984).„Fluperlapine in 104 schizophrenic patients. Open multicenter trial”.Arzneimittel-Forschung34(1A): 125–130.PMID6145428.
↑Woggon,B.;Angst,J.;Bartels,M.;Heinrich,K.;Hippius,H.;Koukkou,M.;Krebs,E.;Küfferle,B.i dr..(1984).„Antipsychotic efficacy of fluperlapine. An open multicenter trial”.Neuropsychobiology11(2): 116–120.PMID6148712.
↑Dieterle,D.;Eben,E.;Einhäupl,K.;Hippius,H.;Klein,H.;Rüther,E.;Schmauß,M.(2008).„The Effect of Fluperlapine in Acute Psychotic Patients”.Pharmacopsychiatry17(2): 57–60.DOI:10.1055/s-2007-1017408.PMID6728910.
↑Woggon,B.;Heinrich,K.;Küfferle,B.;Müller-Oerlinghausen,B.;Pöldinger,W.;Rüther,E.;Schied,H. W.(1984).„Results of a multicenter AMDP study with fluperlapine in schizophrenic patients”.Arzneimittel-Forschung34(1A): 122–124.PMID6145427.
↑Scholz,E.;Dichgans,J.(1985).„Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine”.European archives of psychiatry and neurological sciences235(1): 60–64.PMID2864254.